Inhibition of neuropeptide FF (NPFF)-induced hypothermia and anti-morphine analgesia by RF9, a new selective NPFF receptors antagonist

Regulatory Peptides

Volumn 147, Issue 1-3, 2008, Pages 45-51

  Fang, Quan ^a,b   Wang, Yi Qing ^b   He, Feng ^a   Guo, Jia ^a,b   Chen, Qiang ^b   Wang, Rui ^a,b  

^a HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^b LANZHOU UNIVERSITY   (China)

Author keywords

Antagonist; Anti morphine action; Hypothermia; Neuropeptide FF (NPFF); RF9

Indexed keywords

MORPHINE; NEUROPEPTIDE FF; RECEPTOR BLOCKING AGENT; RF 9; UNCLASSIFIED DRUG;

ANALGESIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG STRUCTURE; HYPOTHERMIA; MALE; MOUSE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING; TEMPERATURE; THERMOREGULATION;

ADAMANTANE; ANALGESICS, OPIOID; ANIMALS; BODY TEMPERATURE; DIPEPTIDES; HYPOTHERMIA; MALE; MICE; MORPHINE; NARCOTIC ANTAGONISTS; OLIGOPEPTIDES; PAIN MEASUREMENT; RECEPTORS, NEUROPEPTIDE;

MUS;

EID: 40849117975     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2007.12.007     Document Type: Article

References (35)

1. Yang H.Y., Fratta W., Majane E.A., and Costa E. Isolation, sequencing, synthesis, and pharmacological characterization of two brain neuropeptides that modulate the action of morphine. Proc Natl Acad Sci U S A 82 (1985) 7757-7761
2. Bonini J.A., Jones K.A., Adham N., Forray C., Artymyshyn R., Durkin M.M., Smith K.E., Tamm J.A., Boteju L.W., Lakhlani P.P., Raddatz R., Yao W.J., Ogozalek K.L., Boyle N., Kouranova E.V., Quan Y., Vaysse P.J., Wetzel J.M., Branchek T.A., Gerald C., et al. Identification and characterization of two G protein-coupled receptors for neuropeptide FF. J Biol Chem 275 (2000) 39324-39331
3. Elshourbagy N.A., Ames R.S., Fitzgerald L.R., Foley J.J., Chambers J.K., Szekeres P.G., Evans N.A., Schmidt D.B., Buckley P.T., Dytko G.M., Murdock P.R., Milligan G., Groarke D.A., Tan K.B., Shabon U., Nuthulaganti P., Wang D.Y., Wilson S., Bergsma D.J., and Sarau H.M. Receptor for the pain modulatory neuropeptides FF and AF is an orphan G protein-coupled receptor. J Biol Chem 275 (2000) 25965-25971
4. Hinuma S., Shintani Y., Fukusumi S., Iijima N., Matsumoto Y., Hosoya M., Fujii R., Watanabe T., Kikuchi K., Terao Y., Yano T., Yamamoto T., Kawamata Y., Habata Y., Asada M., Kitada C., Kurokawa T., Onda H., Nishimura O., Tanaka M., et al. New neuropeptides containing carboxy-terminal RFamide and their receptor in mammals. Nat Cell Biol 2 (2000) 703-708
5. Liu Q., Guan X.M., Martin W.J., McDonald T.P., Clements M.K., Jiang Q., Zeng Z., Jacobson M., Williams Jr. D.L., Yu H., Bomford D., Figueroa D., Mallee J., Wang R., Evans J., Gould R., and Austin C.P. Identification and characterization of novel mammalian neuropeptide FF-like peptides that attenuate morphine-induced antinociception. J Biol Chem 276 (2001) 36961-36969
6. Perry S.J., Yi-Kung Huang E., Cronk D., Bagust J., Sharma R., Walker R.J., Wilson S., and Burke J.F. A human gene encoding morphine modulating peptides related to NPFF and FMRFamide. FEBS Lett 409 (1997) 426-430
7. Vilim F.S., Aarnisalo A.A., Nieminen M.L., Lintunen M., Karlstedt K., Kontinen V.K., Kalso E., States B., Panula P., and Ziff E. Gene for pain modulatory neuropeptide NPFF: induction in spinal cord by noxious stimuli. Mol Pharmacol 55 (1999) 804-811
8. Panula P., Kalso E., Nieminen M., Kontinen V.K., Brandt A., and Pertovaara A. Neuropeptide FF and modulation of pain. Brain Res 848 (1999) 191-196
9. Roumy M., and Zajac J.M. Neuropeptide FF, pain and analgesia. Eur J Pharmacol 345 (1998) 1-11
10. Desprat C., and Zajac J.M. Hypothermic effects of neuropeptide FF analogues in mice. Pharmacol Biochem Behav 58 (1997) 559-563
11. Frances B., Lahlou H., and Zajac J.M. Cholera and pertussis toxins inhibit differently hypothermic and anti-opioid effects of neuropeptide FF. Regul Pept 98 (2001) 13-18
12. Harrison L.M., Kastin A.J., and Zadina J.E. Opiate tolerance and dependence: receptors, G-proteins, and antiopiates. Peptides 19 (1998) 1603-1630
13. Malin D.H., Lake J.R., Hammond M.V., Fowler D.E., Rogillio R.B., Brown S.L., Sims J.L., Leecraft B.M., and Yang H.Y. FMRF-NH2-like mammalian octapeptide: possible role in opiate dependence and abstinence. Peptides 11 (1990) 969-972
14. Allard M., Labrouche S., Nosjean A., and Laguzzi R. Mechanisms underlying the cardiovascular responses to peripheral administration of NPFF in the rat. J Pharmacol Exp Ther 274 (1995) 577-583
15. Prokai L., Zharikova A.D., Juhasz A., and Prokai-Tatrai K. Cardiovascular effects of neuropeptide FF antagonists. Peptides 27 (2006) 1015-1019
16. Roth B.L., Disimone J., Majane E.A., and Yang H.Y. Elevation of arterial pressure in rats by two new vertebrate peptides FLFQPQRF-NH2 and AGEGLSSPFWSLAAPQRF-NH2 which are immunoreactive to FMRF-NH2 antiserum. Neuropeptides 10 (1987) 37-42
17. Panula P., Aarnisalo A.A., and Wasowicz K. Neuropeptide FF, a mammalian neuropeptide with multiple functions. Prog Neurobiol 48 (1996) 461-487
18. Huang E.Y., Li J.Y., Tan P.P., Wong C.H., and Chen J.C. The cardiovascular effects of PFRFamide and PFR(Tic)amide, a possible agonist and antagonist of neuropeptide FF (NPFF). Peptides 21 (2000) 205-210
19. Malin D.H., Lake J.R., Leyva J.E., Hammond M.V., Rogillio R.B., Arcangeli K.R., Ludgate K., Moore G.M., and Payza K. Analog of neuropeptide FF attenuates morphine abstinence syndrome. Peptides 12 (1991) 1011-1014
20. Malin D.H., Lake J.R., Smith D.A., Jones J.A., Morel J., Claunch A.E., Stevens P.A., Payza K., Ho K.K., Liu J., et al. Subcutaneous injection of an analog of neuropeptide FF prevents naloxone-precipitated morphine abstinence syndrome. Drug Alcohol Depend 40 (1995) 37-42
21. Prokai L., Prokai-Tatrai K., Zharikova A., Li X., and Rocca J.R. Combinatorial lead optimization of a neuropeptide FF antagonist. J Med Chem 44 (2001) 1623-1626
22. Tan P.P., Chen J.C., Li J.Y., Liang K.W., Wong C.H., and Huang E.Y. Modulation of naloxone-precipitated morphine withdrawal syndromes in rats by neuropeptide FF analogs. Peptides 20 (1999) 1211-1217
23. Mollereau C., Mazarguil H., Marcus D., Quelven I., Kotani M., Lannoy V., Dumont Y., Quirion R., Detheux M., Parmentier M., and Zajac J.M. Pharmacological characterization of human NPFF(1) and NPFF(2) receptors expressed in CHO cells by using NPY Y(1) receptor antagonists. Eur J Pharmacol 451 (2002) 245-256
24. Engstrom M., Wurster S., Savola J.M., and Panula P. Functional properties of Pfr(Tic)amide and BIBP3226 at human neuropeptide FF2 receptors. Peptides 24 (2003) 1947-1954
25. Fang Q., Guo J., Chang M., Chen L.X., Chen Q., and Wang R. Neuropeptide FF receptors exert contractile activity via inhibition of nitric oxide release in the mouse distal colon. Peptides 26 (2005) 791-797
26. Fang Q., Guo J., He F., Peng Y.L., Chang M., and Wang R. In vivo inhibition of neuropeptide FF agonism by BIBP3226, an NPY Y1 receptor antagonist. Peptides 27 (2006) 2207-2213
27. Mollereau C., Gouarderes C., Dumont Y., Kotani M., Detheux M., Doods H., Parmentier M., Quirion R., and Zajac J.M. Agonist and antagonist activities on human NPFF(2) receptors of the NPY ligands GR231118 and BIBP3226. Br J Pharmacol 133 (2001) 1-4
28. Simonin F., Schmitt M., Laulin J.P., Laboureyras E., Jhamandas J.H., MacTavish D., Matifas A., Mollereau C., Laurent P., Parmentier M., Kieffer B.L., Bourguignon J.J., and Simonnet G. RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperalgesia. Proc Natl Acad Sci U S A 103 (2006) 466-471
29. Jhamandas J.H., Simonin F., Bourguignon J.J., and Harris K.H. Neuropeptide FF and neuropeptide VF inhibit GABAergic neurotransmission in parvocellular neurons of the rat hypothalamic paraventricular nucleus. Am J Physiol 292 (2007) R1872-R1880
30. Fang Q., Guo J., Peng Y.L., Chang M., He F., Chen Q., and Wang R. In vitro and in vivo studies of dansylated compounds, the putative agonists and antagonists on neuropeptide FF receptors. Peptides 27 (2006) 1297-1304
31. Rosow C.E., Miller J.M., Pelikan E.W., and Cochin J. Opiates and thermoregulation in mice. I. Agonists. J Pharmacol Exp Ther 213 (1980) 273-283
32. Quelven I., Roussin A., and Zajac J.M. Comparison of pharmacological activities of neuropeptide FF1 and neuropeptide FF2 receptor agonists. Eur J Pharmacol 508 (2005) 107-114
33. Haley T.J.M.W. Pharmacological effects produced by intracerebral injections of drugs in the conscious mouse. Br J Pharmacol 12 (1957) 12-15
34. Fang Q., He F., Wang Y.Q., Guo J., Zhang B.Z., Chen Q., and Wang R. Pharmacological effects of the dansylated neuropeptide FF analogues on body temperature and morphine analgesia. Neuropeptides 41 (2007) 339-347
35. Roussin A., Serre F., Gouarderes C., Mazarguil H., Roumy M., Mollereau C., and Zajac J.M. Anti-analgesia of a selective NPFF2 agonist depends on opioid activity. Biochem Biophys Res Commun 336 (2005) 197-203